Keep pumping the fear harding, I need more shares at these levels, I really need to retire in two years.
Btx owns 700 patents but as investors are now finding out the majority of those are useless embryonic patents.
MENLO PARK, Calif., June 1, 2015 /PRNewswire/ -- Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company focused on the emerging field of regenerative medicine, today announced positive, new, long-term follow-up data from a Phase 2 clinical trial of AST-VAC1 in patients with intermediate and high risk acute myelogenous leukemia (AML). AST-VAC1 is the Company's autologous (using cells sourced from the patient) telomerase-based dendritic cell cancer vaccine. AML is the most common form of acute leukemia in adults with 12,000 new cases diagnosed annually, and remains an unmet clinical need, especially in patients over the age of 60 who face poor outcomes and have limited therapies available to them. The long-term follow-up showed that more than 50% of patients who received AST-VAC1 had prolonged relapse-free survival, even patients with high-risk AML including those over 60 years old and patients in second remission.
'Smoke & mirrors' are words used in order to create doubt so day traders can buy back in.
Biotime has over 600 key stem cell patents and seven subsidiaries so it's actually a very safe stock to buy and sell. Just be careful not to have all shares sold as we are approaching major upcoming milestones.
PanC-DX cancer diagnostic products on the way as well as GE/BTX drud testing stem cell kits.
Billion dollar pipeline about to flood market.